Management of Pulmonary Mucormycosis After Orthotopic Heart Transplant: A Case Series-Reference-Cited by-同舟云学术

Management of Pulmonary Mucormycosis After Orthotopic Heart Transplant: A Case Series

Published:2021-12 Issue:10 Volume:53 Page:3051-3055
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Hill Michael C.^ORCID,Belkin Mark N.^ORCID,McMullen Phillip,Pillarella Jessica J.,Macaluso Greg P.,Treitman Adam N.,Pappas Pat S.,Tatooles Antone J.,Cotts William G.,Andrade Ambar A.,Kim Gene,Narang Nikhil^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference18 articles.

1. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports;Jeong;Clin Microbiol Infect,2019

2. Pulmonary mucormycosis in a heart transplant patient;Bardwell;Am J Med,2020

3. Monster lung cavity in a heart transplant recipient;Nokes;Heart Surg Forum,2018

4. Surgical treatment of multifocal pulmonary mucormycosis;Mills;Ann Thorac Surg,2018

5. Disseminated mucormycosis masquerading as rejection early after orthotopic heart transplantation;Margoles;Transpl Infect Dis,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Isavuconazole Combined with Nebulized Inhalation and Bronchoscopic Administration of Amphotericin B for the Treatment of Pulmonary Mucormycosis: A Case Report and Literature Review;Journal of Fungi;2024-05-29

2. Epidemiology, Clinical Manifestations, and Outcome of Mucormycosis in Solid Organ Transplant Recipients: A Systematic Review of Reported Cases;Open Forum Infectious Diseases;2024-01-30

3. Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis;Expert Review of Anti-infective Therapy;2023-06-07

4. Immunosuppressants/valaciclovir;Reactions Weekly;2022-02